Neuronetics (STIM) Total Debt Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -0.07% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.11% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 1.72% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -0.34% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -14.39% |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn | 18.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.87% |
| Dec 31, 2025 | 22.63% |
| Sep 30, 2025 | 23.08% |
| Jun 30, 2025 | 16.69% |
| Mar 31, 2025 | 16.71% |
| Dec 31, 2024 | 16.69% |
| Sep 30, 2024 | 9.43% |
| Jun 30, 2024 | 19.58% |
| Mar 31, 2024 | 19.55% |
| Dec 31, 2023 | 19.64% |
| Sep 30, 2023 | 2.18% |
| Jun 30, 2023 | 2.22% |
| Mar 31, 2023 | 2.31% |
| Dec 31, 2022 | 4.90% |
| Sep 30, 2022 | 4.93% |
| Jun 30, 2022 | 4.98% |
| Mar 31, 2022 | 5.05% |
| Dec 31, 2021 | 5.15% |
| Sep 30, 2021 | 5.15% |
| Jun 30, 2021 | 5.22% |
| Dec 31, 2020 | 5.41% |